Risky Research Review Act
Official title: To amend title 31, United States Code, to establish the Life Sciences Research Security Board, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Risky Research Review Act
This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research. High-risk life sciences research means the study of an organism, virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or virulence of certain high-risk pathogens (e.g., Ebola).
Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review.
In making its determinations, the board must consider specified factors, including whether the benefits of the research outweigh the risks. The bill prohibits agencies from awarding federal funding for high-risk life sciences research without approval of the board or for life sciences research currently under board review. The board may also review awards that were made before the bill’s enactment.
Entities that fail to properly attest to the nature of their research may lose their eligibility for funding. Additionally, agency employees who fail to comply with the bill's requirements are subject to disciplinary action.
- Introduced in House Formatted Text PDF Formatted XML
- RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- MICHIGAN STATE UNIVERSITY
- UNIVERSITY OF MICHIGAN
- AMERICAN SOCIETY FOR MICROBIOLOGY
- CORNERSTONE GOVERNMENT AFFAIRS, INC.
- ASSOCIATION OF AMERICAN MEDICAL COLLEGES
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Education, Dept of
- Office of Science & Technology Policy (OSTP)
- Centers For Medicare and Medicaid Services (CMS)
- Agency for Healthcare Research & Quality (AHRQ)
- Centers For Disease Control & Prevention (CDC)
- Commerce, Dept of (DOC)
Cite this page
U.S. Congress. (2026). H.R. 1864: Risky Research Review Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1864/
"H.R. 1864: Risky Research Review Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1864/.
H.R. 1864, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1864/.
[H.R. 1864: Risky Research Review Act](https://openamerica.io/bill/119-HR-1864/)